Abstract
The apolipoprotein E (APOE) ɛ4 allele is associated with elevated cholesterol and risk of atherosclerosis. However, its role in ischemic stroke (IS) remains controversial. We investigated a possible link between IS or the severity of intracranial atherosclerosis and the APOE promoter polymorphisms −219G/T and +113G/C, involved in regulating APOE transcription. We genotyped subjects from a multicentric Belgian case–control study, including 237 middle-aged patients with IS due to small- or large-vessel atherosclerotic stroke and 326 ethnicity- and gender-matched controls and a Finnish autopsy series of 1004 non-stroke cases, who had received a quantitative score of atherosclerosis in the circle of Willis. The APOE ɛ4+ genotype did not associate with IS, but was related to more severe intracranial atherosclerosis score in men (5.4 vs 4.6, P=0.044). Within the most common APOE ɛ3/ɛ3 genotype group, the risk of IS associated with the G-allele of the tightly linked −219G/T (OR=6.2; 95% CI: 1.6–24.3, P=0.009) and +113G/C (OR=7.1; 95% CI: 1.7–29.9, P=0.007) promoter polymorphisms. There was no difference in the severity of intracranial atherosclerosis between −219G/G genotype carriers and non-carriers. This study suggests a multifaceted role of apoE on the risk of cerebrovascular diseases. The APOE ɛ4+ genotype did not predict the risk of IS but was associated with severity of subclinical intracranial atherosclerosis in men on the autopsy study. In contrast, the promoter variants were significant predictors of IS, suggesting that quantitative rather than qualitative variation of apoE is related to IS.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Casas JP, Hingorani AD, Bautista LE, Sharma P : Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18 000 cases and 58 000 controls. Arch Neurol 2004; 61: 1652–1661.
Flossmann E, Schulz UG, Rothwell PM : Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke 2004; 35: 212–227.
Jerrard-Dunne P, Cloud G, Hassan A, Markus HS : Evaluating the genetic component of ischemic stroke subtypes: a family history study. Stroke 2003; 34: 1364–1369.
Polychronopoulos P, Gioldasis G, Ellul J et al: Family history of stroke in stroke types and subtypes. J Neurol Sci 2002; 195: 117–122.
Schulz UG, Flossmann E, Rothwell PM : Heritability of ischemic stroke in relation to age, vascular risk factors, and subtypes of incident stroke in population-based studies. Stroke 2004; 35: 819–824.
Bennet AM, Di Angelantonio E, Ye Z et al: Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 2007; 298: 1300–1311.
Sudlow C, Martinez Gonzalez NA, Kim J, Clark C : Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17 965 controls. Stroke 2006; 37: 364–370.
Slowik A, Iskra T, Turaj W, Hartwich J, Dembinska-Kiec A, Szczudlik A : LDL phenotype B and other lipid abnormalities in patients with large vessel disease and small vessel disease. J Neurol Sci 2003; 214: 11–16.
van Vliet P, Mooijaart SP, de Craen AJ, Rensen PC, van Heemst D, Westendorp RG : Plasma levels of apolipoprotein E and risk of stroke in old age. Ann NY Acad Sci 2007; 1100: 140–147.
Mooijaart SP, Berbee JF, van Heemst D et al: ApoE plasma levels and risk of cardiovascular mortality in old age. PLoS Med 2006; 3: e176.
Artiga MJ, Bullido MJ, Sastre I et al: Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene. FEBS Lett 1998; 421: 105–108.
Lambert JC, Brousseau T, Defosse V et al: Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations–the ECTIM study. Hum Mol Genet 2000; 9: 57–61.
Viiri LE, Loimaala A, Nenonen A et al: The association of the apolipoprotein E gene promoter polymorphisms and haplotypes with serum lipid and lipoprotein concentrations. Atherosclerosis 2005; 179: 161–167.
Viiri LE, Raitakari OT, Huhtala H et al: Relations of APOE promoter polymorphisms to LDL cholesterol and markers of subclinical atherosclerosis in young adults. J Lipid Res 2006; 47: 1298–1306.
Viitanen L, Pihlajamaki J, Miettinen R et al: Apolipoprotein E gene promoter (−219G/T) polymorphism is associated with premature coronary heart disease. J Mol Med 2001; 79: 732–737.
Campbell CD, Ogburn EL, Lunetta KL et al: Demonstrating stratification in a European American population. Nat Genet 2005; 37: 868–872.
Ilveskoski E, Perola M, Lehtimaki T et al: Age-dependent association of apolipoprotein E genotype with coronary and aortic atherosclerosis in middle-aged men: an autopsy study. Circulation 1999; 100: 608–613.
Peltonen L, Pekkarinen P, Aaltonen J : Messages from an isolate: lessons from the Finnish gene pool. Biol Chem Hoppe Seyler 1995; 376: 697–704.
Hixson JE : Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) research group. Arterioscler Thromb 1991; 11: 1237–1244.
Hogh P, Garde E, Mortensen EL, Jorgensen OS, Krabbe K, Waldemar G : The apolipoprotein E epsilon4-allele and antihypertensive treatment are associated with increased risk of cerebral MRI white matter hyperintensities. Acta Neurol Scand 2007; 115: 248–253.
Miyata M, Smith JD : Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 1996; 14: 55–61.
Calara F, Silvestre M, Casanada F, Yuan N, Napoli C, Palinski W : Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice. J Pathol 2001; 195: 257–263.
Wyler von Ballmoos M, Dubler D, Mirlacher M, Cathomas G, Muser J, Biedermann BC : Increased apolipoprotein deposits in early atherosclerotic lesions distinguish symptomatic from asymptomatic patients. Arterioscler Thromb Vasc Biol 2006; 26: 359–364.
van den Elzen P, Garg S, Leon L et al: Apolipoprotein-mediated pathways of lipid antigen presentation. Nature 2005; 437: 906–910.
Weintraub MS, Eisenberg S, Breslow JL : Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 1987; 80: 1571–1577.
Kohlmeier M, Salomon A, Saupe J, Shearer MJ : Transport of vitamin K to bone in humans. J Nutr 1996; 126: 1192S–1196S.
Weir CJ, McCarron MO, Muir KW et al: Apolipoprotein E genotype, coagulation, and survival following acute stroke. Neurology 2001; 57: 1097–1100.
Garcia-Segura LM, Azcoitia I, DonCarlos LL : Neuroprotection by estradiol. Prog Neurobiol 2001; 63: 29–60.
Colton CA, Brown CM, Vitek MP : Sex steroids, APOE genotype and the innate immune system. Neurobiol Aging 2005; 26: 363–372.
Phillips NR, Havel RJ, Kane JP : Sex-related differences in the concentrations of apolipoprotein E in human blood plasma and plasma lipoproteins. J Lipid Res 1983; 24: 1525–1531.
Acknowledgements
We thank the laboratory technicians Nina Peltonen and Ana Lopes Cruz for their help. This study was funded by Erasme Funds, FNRS, Emil Aaltonen Foundation (TL), Medical Research Fund of Tampere University Hospital, the Pirkanmaa Regional Fund of the Finnish Cultural Foundation, the Finnish Foundation for Cardiovascular Research and the Yrjö Jahnsson Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abboud, S., Viiri, L., Lütjohann, D. et al. Associations of apolipoprotein E gene with ischemic stroke and intracranial atherosclerosis. Eur J Hum Genet 16, 955–960 (2008). https://doi.org/10.1038/ejhg.2008.27
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2008.27
Keywords
This article is cited by
-
Causal association of circulating cholesterol levels with dementia: a mendelian randomization meta-analysis
Translational Psychiatry (2020)
-
Genetic Risk Factors of Intracranial Atherosclerosis
Current Atherosclerosis Reports (2020)
-
Pathobiology of tobacco smoking and neurovascular disorders: untied strings and alternative products
Fluids and Barriers of the CNS (2015)
-
Association of an apolipoprotein E polymorphism with circulating cholesterols and hypertension: a meta-based Mendelian randomization analysis
Hypertension Research (2012)
-
Statin Pharmacogenomics: Lipid Response and Cardiovascular Outcomes
Current Cardiovascular Risk Reports (2010)
